Ardian acquires Groupe Bio7 (The Bio 7 Group)

On June 10, 2014, Ardian acquired Groupe Bio7 (The Bio 7 Group), a life science company in France, from Chequers Capital.

Deal at a glance

AnnouncedJune 10, 2014 TypeSecondary Buyout TargetGroupe Bio7 (The Bio 7 Group) Buyer Ardian Seller Chequers Capital SectorLife Science LocationFrance ValueNot disclosed

Target company

Groupe Bio7 (The Bio 7 Group)

France

Life Sciencesector

-founded

Activestatus

View the company profile →

Buyer

Ardian

Private equity firm · 421 deals on record

12th transaction in life science
122nd transaction in France

421deals, all time

20in this sector

2026latest

Seller

Chequers Capital

Private equity firm · 20 deals on record

20investments

1in this sector

12exits

Members only

Contact details at the buyers and sellers

The full deal history of every party

Co-investors and the other advisors on this deal

Deal value and revenue or EBITDA multiples

Related deals

PflegiaSame lead buyer · Jul 2026

Munich Electrification GmbHSame lead buyer · Jul 2026

Taxually Korlatolt Felelossegu TarsasagSame lead buyer · May 2022

Cell&Co BioServicesSame sector and country · Apr 2022

Questions about this deal

Who acquired Groupe Bio7 (The Bio 7 Group)?Ardian acquired Groupe Bio7 (The Bio 7 Group) on June 10, 2014.

Who sold Groupe Bio7 (The Bio 7 Group)?Chequers Capital was the seller.

What type of deal was it?It was a secondary buyout in the life science sector in 2014.

See the full picture on AcquityDataContacts, full deal histories, co-investors and deal values. Free for a day with your Google account, no card needed.

Try it free

Data updated daily on AcquityData (Acquity Data).